Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced 6% HES 130/0.4 vs balanced crystalloid infusion in colorectal surgery
2009-017595-25Phase 4Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hetastarch in colorectal cancer (CRC) and benign colorectal disease (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoint: Total volume of administered fluids intraoperatively. Started Jan 2011; status: terminated.
02
Drugs
hetastarch
03
Conditions
colorectal cancer (CRC)benign colorectal disease
Beyond the preview
Go deeper on 2009-017595-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017595-25.